PSA commences work on revised immunisation practice guidelines
16 November 2026
The Pharmaceutical Society of Australia (PSA) has commenced reviewing the Practice Guidelines for pharmacists providing immunisation services. The revised guidelines will replace the current edition from May 2020 and are expected to be released in June 2027.
While the PSA undertakes its review of the Practice Guidelines, it will also issue interim guidance to support the Australian Government’s expansion of the National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program, funded in the 2026–27 Budget, which will extend the program to children under five from 1 January 2027, where permitted by state and territory legislation.
PSA National President, Professor Mark Naunton MPS, said the profession needs contemporary guidance that reflects state and territory legislative reforms and the expansion of pharmacist-delivered immunisation services.
“As the peak body for Australian pharmacists, PSA has a responsibility to ensure pharmacists and pharmacy staff have clear, up-to-date guidance to support safe, accessible vaccination services,” Professor Naunton said.
“We welcome the Australian Government’s investment in expanding pharmacist vaccination to children under five, and we are pleased to be working with the Department to ensure pharmacists have the guidance they need to help lift childhood vaccination rates.”
Associate Professor Fei Sim FPS, chair of the immunisation practice guidelines project advisory group, said the review presents an important opportunity for pharmacists to shape the future of immunisation practice.
“With significant changes to pharmacist vaccination services commencing from 1 January, now is the time for pharmacists to share their experiences and tell us what support they need in practice,” Associate Professor Sim said.
“These guidelines need to reflect the realities of contemporary pharmacy practice, and the only way we can achieve that is by hearing directly from pharmacists across practice settings and jurisdictions.
“The strongest professional guidance is developed with the profession, not for the profession, so please have your say to help identify the issues, opportunities, and practical guidance that should be addressed in the next edition.”
The PSA encourages all pharmacists to contribute to the review through a national consultation survey, as this feedback will inform the development of the new guidelines to meet the profession’s needs now and in the future. Pharmacists wishing to participate can do so here.
The PSA will host a webinar in January to help pharmacists understand and adopt changes to the NIPVIP Program. Pharmacists are encouraged to attend the Next Step in Pharmacy Vaccination: Under 5s webinar and can register here.
The PSA acknowledges that the review and development of the Practice Guidelines for pharmacists providing immunisation services is supported by funding from the Australian Government.
Media contact: Leah Jacobsen
E: leah.jacobsen@psa.org.au or media@psa.org.au
The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.
